Parkwood LLC’s Genmab GMAB Stock Holding History

Parkwood LLC’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-128,955	Closed	-$4.23M	–	125
2021 Q1	$4.23M	Buy	128,955 +9,169	+8%	+$345K	0.75%	47
2020 Q4	$4.87M	Buy	+119,786	New	+$4.48M	0.59%	54

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Parkwood LLC's GMAB Position: Q2 2021 in Review

Parkwood LLC sold out of Genmab (GMAB) in Q2 2021, closing a stake of 128,955 shares — an estimated $4.23M sold.

Parkwood LLC first reported a position in GMAB in Q4 2020 and held it in 2 quarters. The position peaked at $4.87M in Q4 2020. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

Parkwood LLC reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
Parkwood LLC sold 128,955 Genmab shares in Q2 2021, an estimated $4.23M.
Parkwood LLC first reported a position in Genmab in Q4 2020 and held it in 2 quarters.
Parkwood LLC's Genmab position peaked at $4.87M in Q4 2020.
213 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Parkwood LLC's 13F filing for Q2 2021, filed 13 Aug 2021.